In addition to their benefits for blood sugar and weight management, GLP-1 medications also contribute positively to cardiovascular health by improving lipid profiles and reducing blood pressure
Currently, the Wegovy pen (injection) list price is $1,349 per month, though the company recently announced that it will reduce the price to $675 per month, starting in 2027
About 30 to 40 percent of commercial plans cover Wegovy or Zepbound for obesity, usually with prior authorization requirements (BMI thresholds, documented diet and exercise attempts, sometimes step therapy)
Looking at Promising Findings from Recent Studies 1
This product is widely used in the United States but is not standard practice in the UK
These effects last as long as you keep taking a GLP-1 medication